Malignant potentially fatal asthma: Achievement of remission and the application of an asthma severity index

M. Lowenthal, R. Patterson*, P. A. Greenberger, L. C. Grammer

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Patients fulfilling diagnostic criteria for malignant potentially fatal asthma require aggressive involvement by the physician to prevent avoidable fatalities from asthma. Efforts to overcome barriers to treatment caused by noncompliance are critical to successful care. This report reviews five patients with malignant potentially fatal asthma in remission, in whom noncompliance played the major role in preventing control of asthma. Through patient confrontation and the monitoring of serum concentrations of prednisone and its metabolite prednisolone, noncompliance may be addressed. Psychiatric referral may also be of benefit, if accepted by the patient and family. Use of injectable methylprednisolone may be a necessary alternative to prevent life-threatening complications of asthma. In all patients, keeping medical regimens as simple as possible is advocated, with the use of the lowest doses of medication necessary to maintain the control of symptoms, and the prevention of morbidity and mortality. An asthma severity index for the illustration of longitudinal disease severity is applied to these patients.

Original languageEnglish (US)
Pages (from-to)333-339
Number of pages7
JournalAllergy Proceedings
Volume14
Issue number5
DOIs
StatePublished - 1993

ASJC Scopus subject areas

  • Immunology and Allergy

Fingerprint Dive into the research topics of 'Malignant potentially fatal asthma: Achievement of remission and the application of an asthma severity index'. Together they form a unique fingerprint.

Cite this